211 related articles for article (PubMed ID: 22072613)
41. [Effects of rho-kinase inhibitor on cardiac hypertrophy of left ventricle in spontaneously hypertensive rats].
Zhang ZJ; Fan YF; Zhang ZY; Xie PY; Fang HC; Su YS
Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(48):3438-41. PubMed ID: 23327708
[TBL] [Abstract][Full Text] [Related]
42. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, ameliorates hepatic fibrosis in rats with type 2 diabetes.
Zhou H; Fang C; Zhang L; Deng Y; Wang M; Meng F
Chin Med J (Engl); 2014; 127(2):225-31. PubMed ID: 24438608
[TBL] [Abstract][Full Text] [Related]
43. Nicorandil regulates the macrophage skewing and ameliorates myofibroblasts by inhibition of RhoA/Rho-kinase signalling in infarcted rats.
Lee TM; Lin SZ; Chang NC
J Cell Mol Med; 2018 Feb; 22(2):1056-1069. PubMed ID: 29119680
[TBL] [Abstract][Full Text] [Related]
44. Fasudil, an inhibitor of Rho-associated coiled-coil kinase, attenuates hyperoxia-induced pulmonary fibrosis in neonatal rats.
Qi XJ; Ning W; Xu F; Dang HX; Fang F; Li J
Int J Clin Exp Pathol; 2015; 8(10):12140-50. PubMed ID: 26722398
[TBL] [Abstract][Full Text] [Related]
45. Fasudil alleviates hepatic fibrosis in type 1 diabetic rats: involvement of the inflammation and RhoA/ROCK pathway.
Xie Y; Song T; Huo M; Zhang Y; Zhang YY; Ma ZH; Wang N; Zhang JP; Chu L
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5665-5677. PubMed ID: 30229844
[TBL] [Abstract][Full Text] [Related]
46. Could pharmacological curtailment of the RhoA/Rho-kinase pathway reverse the endothelial barrier dysfunction associated with Ebola virus infection?
Eisa-Beygi S; Wen XY
Antiviral Res; 2015 Feb; 114():53-6. PubMed ID: 25512227
[TBL] [Abstract][Full Text] [Related]
47. Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension.
Waddingham MT; Edgley AJ; Astolfo A; Inagaki T; Fujii Y; Du CK; Zhan DY; Tsuchimochi H; Yagi N; Kelly DJ; Shirai M; Pearson JT
Cardiovasc Diabetol; 2015 Jul; 14():92. PubMed ID: 26194354
[TBL] [Abstract][Full Text] [Related]
48. Fasudil, a Rho-associated protein kinase inhibitor, attenuates retinal ischemia and reperfusion injury in rats.
Song H; Gao D
Int J Mol Med; 2011 Aug; 28(2):193-8. PubMed ID: 21455561
[TBL] [Abstract][Full Text] [Related]
49. Simultaneous Rho kinase inhibition in circulating leukocytes and in cardiovascular tissue in rats with high angiotensin converting enzyme levels.
Fierro C; Novoa U; González V; Ocaranza MP; Jalil JE
Int J Cardiol; 2016 Jul; 215():309-17. PubMed ID: 27128553
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice.
Wang YX; da Cunha V; Martin-McNulty B; Vincelette J; Li W; Choy DF; Halks-Miller M; Mahmoudi M; Schroeder M; Johns A; Light DR; Dole WP
Eur J Pharmacol; 2005 Apr; 512(2-3):215-22. PubMed ID: 15840407
[TBL] [Abstract][Full Text] [Related]
51. Fasudil alleviated insulin resistance through promotion of proliferation, attenuation of cell apoptosis and inflammation and regulation of RhoA/Rho kinase/insulin/nuclear factor-κB signalling pathway in HTR-8/SVneo cells.
Bai Y; Du Q; Zhang L; Li L; Tang L; Zhang W; Du R; Li P; Li L
J Pharm Pharmacol; 2021 Jul; 73(8):1118-1127. PubMed ID: 33779714
[TBL] [Abstract][Full Text] [Related]
52. Fasudil protects against isoproterenol-induced myocardial infarction in mice via inhibiting Rho/ROCK signaling pathway.
Zhou FT; Ma K
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5659-5667. PubMed ID: 32495901
[TBL] [Abstract][Full Text] [Related]
53. Fasudil ameliorates the ischemia/reperfusion oxidative injury in rat hearts through suppression of myosin regulatory light chain/NADPH oxidase 2 pathway.
Zhang YS; Tang LJ; Tu H; Wang SJ; Liu B; Zhang XJ; Li NS; Luo XJ; Peng J
Eur J Pharmacol; 2018 Mar; 822():1-12. PubMed ID: 29337194
[TBL] [Abstract][Full Text] [Related]
54. [The effect of fasudil via Rho/ROCK signaling pathway on the inflammation and fibrosis in human mesangial cells in high glucose medium].
Ma DW; Wang QY; Ma XY; Li J; Guan QH; Fu Y
Zhonghua Nei Ke Za Zhi; 2011 Jul; 50(7):580-4. PubMed ID: 22041269
[TBL] [Abstract][Full Text] [Related]
55. Role of a RhoA/ROCK-Dependent Pathway on Renal Connexin43 Regulation in the Angiotensin II-Induced Renal Damage.
Gómez GI; Velarde V; Sáez JC
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500276
[TBL] [Abstract][Full Text] [Related]
56. Involvement of sphingosine-1-phosphate/RhoA/Rho-kinase signaling pathway in corporal fibrosis following cavernous nerve injury in male rats.
Cho MC; Park K; Chai JS; Lee SH; Kim SW; Paick JS
J Sex Med; 2011 Mar; 8(3):712-21. PubMed ID: 21143420
[TBL] [Abstract][Full Text] [Related]
57. Fasudil, an inhibitor of Rho-associated coiled-coil kinase, improves cognitive impairments induced by smoke exposure.
Xueyang D; Zhanqiang M; Chunhua M; Kun H
Oncotarget; 2016 Nov; 7(48):78764-78772. PubMed ID: 27791202
[TBL] [Abstract][Full Text] [Related]
58. Role of Rho kinase and oxidative stress in cardiac fibrosis induced by aldosterone and salt in angiotensin type 1a receptor knockout mice.
Kagiyama S; Matsumura K; Goto K; Otsubo T; Iida M
Regul Pept; 2010 Feb; 160(1-3):133-9. PubMed ID: 19969025
[TBL] [Abstract][Full Text] [Related]
59. [Effects of the Rho-kinase inhibitor fasudil on the invasion, migration, and apoptosis of human prostate cancer PC3 and DU145 cells].
Gao QQ; Chen H; Chen Y; Xu ZP; Zhu LL; Yu W; Han YF; Dai YT
Zhonghua Nan Ke Xue; 2016 Jun; 22(6):483-490. PubMed ID: 28963834
[TBL] [Abstract][Full Text] [Related]
60. Rho kinase inhibition by fasudil attenuates cyclosporine-induced kidney injury.
Park JW; Park CH; Kim IJ; Bae EH; Ma SK; Lee JU; Kim SW
J Pharmacol Exp Ther; 2011 Jul; 338(1):271-9. PubMed ID: 21474569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
